Cargando…

Efficacy and Safety of High-Density Lipoprotein/Apolipoprotein A1 Replacement Therapy in Humans and Mice With Atherosclerosis: A Systematic Review and Meta-Analysis

Background: Although elevation of HDL-C levels by pharmaceutical drugs have no benefit of cardiovascular endpoint, the effect of high-density lipoprotein/apolipoprotein A1 (HDL/apoA-1) replacement therapy on atherosclerosis is controversial. The current meta-analysis analyzed the effects of HDL/apoA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abudukeremu, Ayiguli, Huang, Canxia, Li, Hongwei, Sun, Runlu, Liu, Xiao, Wu, Xiaoying, Xie, Xiangkun, Huang, Jingjing, Zhang, Jie, Bao, Jinlan, Zhang, Yuling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377725/ https://www.ncbi.nlm.nih.gov/pubmed/34422927 http://dx.doi.org/10.3389/fcvm.2021.700233

Ejemplares similares

Proteomic and functional analysis of HDL subclasses in humans and rats: a proof-of-concept study
por: Huang, Canxia, et al.
Publicado: (2023)

Insulin Rescued MCP-1-Suppressed Cholesterol Efflux to Large HDL2 Particles via ABCA1, ABCG1, SR-BI and PI3K/Akt Activation in Adipocytes
por: Sun, Runlu, et al.
Publicado: (2021)

Large HDL(2) combined with inflammatory factors as superior predictors for coronary artery disease than small HDL(3)
por: Wu, Xiaoying, et al.
Publicado: (2021)

Association of renal cyst and type A acute aortic dissection with hypertension
por: Bao, Jinlan, et al.
Publicado: (2020)

Dietary-Induced Elevations of Triglyceride-Rich Lipoproteins Promote Atherosclerosis in the Low-Density Lipoprotein Receptor Knockout Syrian Golden Hamster
por: Lin, Xiao, et al.
Publicado: (2021)

Endothelial Transcytosis of Lipoproteins in Atherosclerosis
por: Zhang, Xinbo, et al.
Publicado: (2018)

The Role of Iron in Atherosclerosis in Apolipoprotein E Deficient Mice
por: Ma, Juan, et al.
Publicado: (2022)

Low Molecular Weight Apolipoprotein(a) Phenotype Rather Than Lipoprotein(a) Is Associated With Coronary Atherosclerosis and Myocardial Infarction
por: Afanasieva, Olga I., et al.
Publicado: (2022)

The Dual Role of Low-Density Lipoprotein Receptor-Related Protein 1 in Atherosclerosis
por: Chen, Jiefang, et al.
Publicado: (2021)

Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies
por: Jin, Xiao, et al.
Publicado: (2022)

Corrigendum: The dual role of low-density lipoprotein receptor–related protein 1 in atherosclerosis
por: Chen, Jiefang, et al.
Publicado: (2023)

Usefulness of B‐Type Natriuretic Peptide for Predicting the Risk of Stroke in Patients With Heart Failure With Preserved Ejection Fraction
por: Liu, Xiao, et al.
Publicado: (2022)

Association of motor index scores with fall incidence among community-dwelling older people
por: Liu, Xiao, et al.
Publicado: (2022)

High Density Lipoprotein and Its Precursor Protein Apolipoprotein A1 as Potential Therapeutics to Prevent Anthracycline Associated Cardiotoxicity
por: Kluck, George E. G., et al.
Publicado: (2020)

The Predictive Value of Carotid Ultrasonography With Cardiovascular Risk Factors—A “SPIDER” Promoting Atherosclerosis
por: Li, Hongwei, et al.
Publicado: (2021)

High‐Density Lipoprotein Subspecies Defined by Apolipoprotein C‐III and Subclinical Atherosclerosis Measures: MESA (The Multi‐Ethnic Study of Atherosclerosis)
por: Aroner, Sarah A., et al.
Publicado: (2018)

Helicobacter pylori Infection Acts as an Independent Risk Factor for Intracranial Atherosclerosis in Women Less Than 60 Years Old
por: Guo, Yinjie, et al.
Publicado: (2022)

U-shaped association between the triglyceride–glucose index and atrial fibrillation incidence in a general population without known cardiovascular disease
por: Liu, Xiao, et al.
Publicado: (2023)

Decreased low-density lipoprotein receptor-related protein 1 expression in pro-inflammatory monocytes is associated with subclinical atherosclerosis
por: Albertini, Ricardo A., et al.
Publicado: (2022)

Development and validation of a prognostic nomogram for myocardial infarction patients in intensive care units: a retrospective cohort study
por: Guo, Qi, et al.
Publicado: (2020)

Heart Rate Fluctuation and Mortality in Critically Ill Myocardial Infarction Patients: A Retrospective Cohort Study
por: Guo, Qi, et al.
Publicado: (2021)

Glycation of LDL: AGEs, impact on lipoprotein function, and involvement in atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2023)

Nicotinamide Prevents Apolipoprotein B-Containing Lipoprotein Oxidation, Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice
por: Méndez-Lara, Karen Alejandra, et al.
Publicado: (2020)

Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: A systematic review and meta-analysis
por: Hong, Christin G., et al.
Publicado: (2023)

Apolipoprotein M promotes the anti-inflammatory effect of high-density lipoprotein by binding to scavenger receptor BI
por: Yao, Shuang, et al.
Publicado: (2020)

High density lipoprotein mimicking nanoparticles for atherosclerosis
por: Chen, Jun, et al.
Publicado: (2020)

Low-density lipoprotein particles in atherosclerosis
por: Qiao, Ya-Nan, et al.
Publicado: (2022)

The Apolipoprotein C-I Content of Very-Low-Density Lipoproteins Is Associated with Fasting Triglycerides, Postprandial Lipemia, and Carotid Atherosclerosis
por: Hansen, John-Bjarne, et al.
Publicado: (2011)

Association of High‐Density Lipoprotein Particles and High‐Density Lipoprotein Apolipoprotein C‐III Content With Cardiovascular Disease Risk According to Kidney Function: The Multi‐Ethnic Study of Atherosclerosis
por: Lamprea‐Montealegre, Julio A., et al.
Publicado: (2019)

Volanesorsen, an Antisense Oligonucleotide to Apolipoprotein-CIII, Decreases Triglycerides and Increases Lipoprotein Lipase Activity in Partial Lipodystrophy
por: Lightbourne, Marissa, et al.
Publicado: (2021)

Apolipoprotein E and Atherosclerosis: From Lipoprotein Metabolism to MicroRNA Control of Inflammation
por: Bouchareychas, Laura, et al.
Publicado: (2018)

Interactions of Apolipoprotein A-I with High-Density Lipoprotein Particles
por: Nguyen, David, et al.
Publicado: (2013)

No Significant Role for Smooth Muscle Cell Mineralocorticoid Receptors in Atherosclerosis in the Apolipoprotein-E Knockout Mouse Model
por: Moss, M. Elizabeth, et al.
Publicado: (2018)

High Density Lipoproteins: Metabolism, Function, and Therapeutic Potential
por: Jomard, Anne, et al.
Publicado: (2020)

High density lipoproteins and atherosclerosis: emerging aspects
por: Sala, Federica, et al.
Publicado: (2012)

Autoimmune Regulator (AIRE) Deficiency Does Not Affect Atherosclerosis and CD4 T Cell Immune Tolerance to Apolipoprotein B
por: Nettersheim, Felix Sebastian, et al.
Publicado: (2022)

Beef in an Optimal Lean Diet study: effects on lipids, lipoproteins, and apolipoproteins(1)(2)(3)
por: Roussell, Michael A, et al.
Publicado: (2012)

Baseline Low-Density-Lipoprotein Cholesterol Modifies the Risk of All-Cause Death Associated With Elevated Lipoprotein(a) in Coronary Artery Disease Patients
por: Yao, Younan, et al.
Publicado: (2022)

Why Should We Measure Low-Density Lipoprotein Cholesterol Directly? Comparison of Low-Density Lipoprotein Cholesterol Assessment by Friedewald Estimation, and Direct Measurement
por: Cohen, Hofit
Publicado: (2021)

Achieved low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio predicts the pathophysiological evolution of lipid-rich plaques in acute coronary syndromes: an optical coherence tomography study
por: He, Luping, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1apag10qefn5ec30l3dr2t83h1